Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Schrodinger, Inc. (SDGR) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 8-K/A Quarterly results
Docs: "Schrödinger Reports Second Quarter 2023 Financial Results Announces IND Clearance for CDC7 Inhibitor SGR-2921, Continued Progress for MALT1 Inhibitor SGR-1505 Delivers Second Quarter Total Revenue of $35.2 Million"
08/04/2022 8-K Quarterly results
05/04/2022 8-K Quarterly results
02/24/2022 8-K Quarterly results
11/10/2021 8-K Quarterly results
Docs: "Schrödinger Reports Third Quarter 2021 Financial Results and Provides Company Update Third Quarter Total Revenue of $29.9 Million, Up 16 Percent Year-Over-Year; Software Revenue of $24.3 Million"
05/11/2021 8-K Quarterly results
03/04/2021 8-K Quarterly results
11/12/2020 8-K Quarterly results
Docs: "Schrödinger, Inc. Reports Third Quarter 2020 Financial Results and Business Update Total revenue of $25.8 million, up 29% year-over-year; Software revenue of $22.9 million, up 42% year-over-year"
08/10/2020 8-K Quarterly results
Docs: "Drug Discovery – Entered into two strategic partnerships to expand the availability of high-resolution structures of protein complexes, which will increase the number of targets available for structure-based drug design o Viva Biotech - to access new x-ray crystal structures for high-value targets o Thermo Fisher Scientific - to leverage the capabilities of the leader in cryo-EM to obtain structures of protein complexes that may not be amenable to x-ray crystallography • Materials Science – Entered into three-year agreement with Gates Ventures to develop and apply atomistic simulation methods to improve battery performance Advancing collaborative and wholly-owned drug discovery programs • 12 internal and collaboration programs in late-stage discovery, including three wholly-o..."
05/13/2020 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : May 13, 2020 Schrödinger, Inc. Delaware 95-4284541 001-39206 120 West 45 th Street, 17 th Floor 10036 Registrant's telephone number, including area code: 295-5800 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commenceme...",
"Schrödinger Reports First Quarter 2020 Financial Results and Recent Business Updates"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy